By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Pharma-Bio Serv, Inc.

Pharma-Bio Serv, Inc. (PBSV)

OTC Currency in USD
$0.60
-$0.01
-1.00%
Last Update: 3 Sept 2025, 19:45
$13.76M
Market Cap
1.66
P/E Ratio (TTM)
12.50%
Forward Dividend Yield
$0.31 - $0.67
52 Week Range

PBSV Stock Price Chart

Explore Pharma-Bio Serv, Inc. interactive price chart. Choose custom timeframes to analyze PBSV price movements and trends.

PBSV Company Profile

Discover essential business fundamentals and corporate details for Pharma-Bio Serv, Inc. (PBSV) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Healthcare Information Services

IPO Date

7 May 2007

Employees

75.00

CEO

Victor Sanchez

Description

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies in Puerto Rico, the United States, Europe, and Brazil. Its technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.

PBSV Financial Timeline

Browse a chronological timeline of Pharma-Bio Serv, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 16 Mar 2026

Upcoming earnings on 27 Jan 2026

Upcoming earnings on 15 Sept 2025

EPS estimate is $0.03, while revenue estimate is $3.00M.

Earnings released on 16 Jun 2025

EPS came in at $0.00 falling short of the estimated $0.03 by -86.13%, while revenue for the quarter reached $2.42M , missing expectations by -19.43%.

Earnings released on 17 Mar 2025

EPS came in at $0.00 falling short of the estimated $0.02 by -98.15%, while revenue for the quarter reached $2.47M , missing expectations by -8.47%.

Earnings released on 29 Jan 2025

EPS came in at $0.00 falling short of the estimated $0.03 by -97.67%, while revenue for the quarter reached $2.33M , missing expectations by -41.67%.

Dividend declared on 29 Jan 2025

A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 20 Mar 2025.

Earnings released on 16 Sept 2024

EPS came in at -$0.01 falling short of the estimated -$0.00 by -146.91%, while revenue for the quarter reached $2.42M , missing expectations by -39.55%.

Earnings released on 14 Jun 2024

EPS came in at -$0.01 falling short of the estimated -$0.00 by -129.89%, while revenue for the quarter reached $2.38M , missing expectations by -20.75%.

Earnings released on 18 Mar 2024

EPS came in at -$0.01 falling short of the estimated -$0.01 by -49.93%, while revenue for the quarter reached $2.38M , missing expectations by -33.85%.

Earnings released on 29 Jan 2024

EPS came in at -$0.00 falling short of the estimated $0.03 by -106.83%, while revenue for the quarter reached $3.60M , missing expectations by -28.04%.

Dividend declared on 21 Dec 2023

A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 15 Feb 2024.

Earnings released on 14 Sept 2023

EPS came in at $0.02 matching the estimated $0.02, while revenue for the quarter reached $4.58M , missing expectations by -15.24%.

Earnings released on 14 Jun 2023

EPS came in at $0.02 matching the estimated $0.02, while revenue for the quarter reached $4.56M , missing expectations by -8.74%.

Earnings released on 17 Mar 2023

EPS came in at $0.02 surpassing the estimated $0.01 by +100.00%, while revenue for the quarter reached $4.24M , missing expectations by -15.23%.

Dividend declared on 1 Mar 2023

A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 14 Apr 2023.

Earnings released on 30 Jan 2023

EPS came in at $0.01 , while revenue for the quarter reached $4.64M .

Earnings released on 14 Sept 2022

EPS came in at $0.01 , while revenue for the quarter reached $4.77M , missing expectations by -77.79%.

Earnings released on 14 Jun 2022

EPS came in at $0.01 , while revenue for the quarter reached $4.97M , missing expectations by -76.90%.

Earnings released on 17 Mar 2022

EPS came in at $0.01 , while revenue for the quarter reached $5.02M .

Dividend declared on 18 Feb 2022

A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 15 Mar 2022.

Earnings released on 11 Feb 2022

EPS came in at -$0.21 , while revenue for the quarter reached $5.60M .

Dividend declared on 10 Dec 2021

A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 3 Jan 2022.

Earnings released on 14 Sept 2021

EPS came in at $0.10 , while revenue for the quarter reached $4.99M .

Earnings released on 14 Jun 2021

EPS came in at $0.01 , while revenue for the quarter reached $5.04M .

Earnings released on 17 Mar 2021

EPS came in at $0.01 , while revenue for the quarter reached $4.49M .

Earnings released on 1 Feb 2021

EPS came in at $0.01 , while revenue for the quarter reached $5.03M , missing expectations by -75.61%.

Dividend declared on 22 Jan 2021

A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 5 Feb 2021.

Earnings released on 14 Sept 2020

EPS came in at $0.03 , while revenue for the quarter reached $6.28M .

PBSV Stock Performance

Access detailed PBSV performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run